CMS Proposes 2027 ACA Marketplace Changes to Address Rising Premiums

Why It Matters

The proposals target premium inflation and enrollment erosion, directly affecting consumer affordability and insurer profitability in the ACA market. Their adoption could redefine competition, risk adjustment, and subsidy structures for millions of shoppers.

Key Takeaways

• Non‑network plans eligible for ACA marketplaces
• Catastrophic plans can be offered up to ten years
• ECP participation threshold lowered from 35% to 20%
• States may certify network standards, shifting oversight
• CMS seeks comment on adjusting medical‑loss‑ratio rules

Pulse Analysis

Rising premiums and the lapse of enhanced subsidies have left the ACA individual market in a precarious position, with enrollment already down by roughly 1.2 million year‑over‑year. CMS’s 2027 rule proposal seeks to arrest this decline by expanding plan design flexibility and tightening cost controls. By permitting non‑network plans that meet essential health benefit standards, the agency hopes to inject price transparency and reduce administrative overhead, potentially lowering premium growth for consumers still navigating a volatile marketplace.

The rule’s most visible changes revolve around catastrophic coverage and network composition. Catastrophic plans could now be offered for up to a decade and become accessible to individuals whose incomes fall outside traditional subsidy brackets, a move that may shift demand toward lower‑premium, high‑out‑of‑pocket products. Simultaneously, CMS proposes to cut the essential community provider participation requirement from 35% to 20% and allow states to certify network adequacy, a shift that could streamline provider contracts but also raise concerns for safety‑net hospitals. Adjustments to risk‑adjustment methodology and a review of the 80% medical‑loss‑ratio rule signal a broader effort to align incentives with market stability.

If enacted, these reforms could reshape the competitive landscape for insurers, prompting product innovation while pressuring legacy plans to adapt pricing strategies. Consumers may benefit from greater plan choice and potentially lower premiums, yet the expanded catastrophic options could increase out‑of‑pocket exposure for high‑use patients. Politically, the proposals navigate a contentious arena where subsidy extensions remain stalled, making CMS’s rule a pivotal lever for preserving ACA market viability ahead of the 2027 enrollment cycle.